Compare ANIX & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | PAI |
|---|---|---|
| Founded | 1982 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 118.3M |
| IPO Year | 1987 | N/A |
| Metric | ANIX | PAI |
|---|---|---|
| Price | $3.18 | $12.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 256.6K | 25.0K |
| Earning Date | 01-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.12 | $10.59 |
| 52 Week High | $5.46 | $12.63 |
| Indicator | ANIX | PAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 55.42 |
| Support Level | $3.07 | $12.47 |
| Resistance Level | $3.36 | $12.68 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 23.08 | 40.91 |
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.